Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOUS
5276
DELISTED
Anywhere Real Estate
HOUS
| $2.33M | ﹤0.01% |
707,002
-322,557
| -31% | -$1.38M |
|
5277
CALL
Graphic Packaging
GPK
$3.44B
| $2.33M | ﹤0.01% |
85,900
+50,600
| +143% | +$1.46M |
|
|
TEM
5278
CALL
Tempus AI
TEM
$12B
| $2.33M | ﹤0.01% |
69,100
-182,900
| -73% | -$9.04M |
|
5279
CALL
Sonoco
SON
$5.77B
| $2.33M | ﹤0.01% |
47,600
-23,200
| -33% | -$1.2M |
|
5280
CALL
Gen Digital
GEN
$16.9B
| $2.32M | ﹤0.01% |
84,900
-108,100
| -56% | -$3.11M |
|
5281
PUT
Grindr
GRND
$2.72B
| $2.32M | ﹤0.01% |
130,300
-32,400
| -20% | -$472K |
|
5282
Goldman Sachs MarketBeta Emerging Markets Equity ETF
GSEE
$137M
| $2.32M | ﹤0.01% |
53,696
-72,858
| -58% | -$3.39M |
|
5283
Corpay
CPAY
$27.1B
| $2.32M | ﹤0.01% |
6,863
-143,482
| -95% | -$50.4M |
|
5284
Royal Gold
RGLD
$21.4B
| $2.32M | ﹤0.01% |
17,584
-209,639
| -92% | -$30.3M |
|
5285
Vera Therapeutics
VERA
$2.25B
| $2.32M | ﹤0.01% |
54,806
+51,736
| +1,685% | +$2.29M |
|
5286
BlueLinx
BXC
$652M
| $2.32M | ﹤0.01% |
22,669
-3,402
| -13% | -$390K |
|
|
UCB
5287
United Community Banks
UCB
$4.28B
| $2.32M | ﹤0.01% |
71,675
-354,369
| -83% | -$11M |
|
5288
PUT
Build-A-Bear
BBW
$474M
| $2.32M | ﹤0.01% |
50,300
+47,900
| +1,996% | +$1.86M |
|
|
BRSL
5289
PUT
Brightstar Lottery PLC
BRSL
$2.12B
| $2.32M | ﹤0.01% |
131,100
-63,900
| -33% | -$1.26M |
|
5290
Lyell Immunopharma
LYEL
$376M
| $2.32M | ﹤0.01% |
187,737
+187,648
| +210,840% | +$3.72M |
|
5291
Revolve Group
RVLV
$1.72B
| $2.31M | ﹤0.01% |
69,007
-590,220
| -90% | -$18.3M |
|
5292
CALL
Vermilion Energy
VET
$1.96B
| $2.31M | ﹤0.01% |
245,800
-228,300
| -48% | -$2.22M |
|
5293
CALL
Boston Beer
SAM
$1.96B
| $2.31M | ﹤0.01% |
7,700
-25,000
| -76% | -$7.55M |
|
|
MESO
5294
PUT
Mesoblast
MESO
$2.26B
| $2.31M | ﹤0.01% |
116,650
+64,750
| +125% | +$717K |
|
5295
BondBloxx BBB Rated 1-5 Year Corporate Bond ETF
BBBS
$180M
| $2.31M | ﹤0.01% |
45,721
+35,041
| +328% | +$1.78M |
|
5296
Cactus
WHD
$5.52B
| $2.31M | ﹤0.01% |
39,506
-90,164
| -70% | -$5.66M |
|
5297
PUT
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.1B
| $2.3M | ﹤0.01% |
33,500
+14,000
| +72% | +$942K |
|
5298
PUT
Eos Energy Enterprises
EOSE
$1.26B
| $2.3M | ﹤0.01% |
473,400
+129,500
| +38% | +$419K |
|
5299
Consensus Cloud Solutions
CCSI
$682M
| $2.3M | ﹤0.01% |
96,416
-57,066
| -37% | -$1.34M |
|
5300
AnaptysBio
ANAB
$1.68B
| $2.3M | ﹤0.01% |
173,727
-31,818
| -15% | -$771K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.